The firm helps gene therapy and vaccine companies develop and manufacture products for rare diseases.
Image: Vigene Biosciences, led by CEO Zairen Sun, right, and Chief Commercial Officer Jeffrey Hung, has been acquired. EMAN MOHAMMED
{iframe}https://www.bizjournals.com/washington/news/2021/06/29/vigene-biosciences-acquired-charles-river.html{/iframe}